Sign inJoin waitlistJoin the waitlist

Kenneth Merrell

Assistant Professor of Radiation Oncology · Mayo Clinic College of Medicine and Science

Credentials: · · ·

History

Mayo Clinic College of Medicine and Science
Present

Radiation Oncology
Mayo Clinic College of Medicine and Science
2012–2016
Preliminary or Transitional Year
2011–2012
Medical College of Wisconsin
2007–2011

Research

Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer
Radiotherapy and Oncology · 2017 · 89 citations
A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer
Advances in Radiation Oncology · 2019 · Last of 12 authors · Corresponding · 88 citations
Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes
Annals of Surgery · 2019 · 85 citations

Chris Hallemeier
40 papers
Michael Haddock
32 papers
Kenneth Olivier
21 papers
Roman Kowalchuk
19 papers · 17 as a resident
Sean Park
19 papers
Dawn Owen
18 papers
Krishan Jethwa
17 papers · 4 as a resident
William Breen
16 papers · 9 as a resident
Brad Stish
13 papers
Paul Brown
13 papers
Terence Sio
13 papers · 1 as a resident
Trey Mullikin
13 papers · 8 as a resident

Clinical trials

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Principal investigator · Recruiting · Phase 2
Mayo Clinic
2020–2032
A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer
Principal investigator · Completed
Mayo Clinic
2018–2026
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
Site PI · Recruiting
Varian, a Siemens Healthineers Company
2023–2030
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Site PI · Recruiting · Phase 3
NRG Oncology
2017–2032